RecruitingNot Applicable

RTMS for CHR Based on Personalized Targets Using Magnetoencephalography

China26 participantsStarted 2025-02-07

Plain-language summary

This study is an before-after study in the same subject, which enrolled 26 individuals with high-risk psychiatric syndrome (CHR). The target of subjects intervention relies on the results of magnetoencephalography localization. The medication and dosage remain unchanged during the intervention period or not yet taking antipsychotic medication. The investigators assume that the intervention targets for each CHR subject are individualized.

Who can participate

Age range13 Years – 35 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical diagnosis of Clinical High-Risk Syndrome for Psychosis * Must be able to right-handed * Primary school education or above * Understand and sign a written informed consent form (jointly signed by the guardian and the participant if under 18 years old) Exclusion Criteria: * Major physical illnesses (organic lesions such as sensory and motor disorders, neurological disorders, and traumatic brain injury) * Taboo symptoms for rTMS treatment (such as intracranial metal implants) * Metal (including orthodontic treatment, dental implants) and tattoos inside the body * Claustrophobia

What they're measuring

Reduction rate of the SIPS/SOPS scale

Timeframe: From enrolment to the end of the 2-week pseudostimulation treatment. From 2 weeks rest after the end of pseudostimulation treatment to the end of 2 weeks of true stimulation treatment.

Trial details

NCT IDNCT06802952

SponsorShanghai Mental Health Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Yegang Hu, Doctor

+86-21-52219305 yeganghu@126.com

View on ClinicalTrials.gov More Clinical High-risk Syndrome of Psychosis trials